UBS O'Connor’s Biohaven BHVN Stock Holding History

UBS O'Connor’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23,000	Closed	-$110K	–	554
2024 Q1	$110K	Buy	+23,000	New	+$1.14M	﹤0.01%	421
2023 Q3	–	Sell	-20,000	Closed	-$18K	–	574
2023 Q2	$18K	Buy	+20,000	New	+$344K	﹤0.01%	532

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

UBS O'Connor's BHVN Position: Q1 2023 in Review

UBS O'Connor sold out of Biohaven (BHVN) in Q1 2023, closing a stake of 488,800 shares — an estimated $6.79M sold.

UBS O'Connor first reported a position in BHVN in Q4 2022 and held it in 1 quarter. The position peaked at $6.79M in Q4 2022. 176 funds tracked by Wall St. Rank hold BHVN as of Q1 2023.

UBS O'Connor reported no remaining Biohaven position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 488,800 Biohaven shares in Q1 2023, an estimated $6.79M.
UBS O'Connor first reported a position in Biohaven in Q4 2022 and held it in 1 quarter.
UBS O'Connor's Biohaven position peaked at $6.79M in Q4 2022.
176 funds tracked by Wall St. Rank held Biohaven as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.